Elevation of serum tenascin‐C levels in dermatomyositis patients

tendency for lower organ involvement of cardiac injury in DM-ILD patients with cardiac injuries could be a potential reason. In conclusion, measurement of serum tenascin-C levels might be an important means to predict cardiac damage in DM patients. Serum tenascin-C levels were elevated irrespective of disease ac - tivity, and tenascin-C might be a novel biomarker to reflect disease state and minor cardiovascular involvement among DM patients.

• Publication year

  2023

• Venue

  International Journal of Rheumatic Diseases

• Publication date

  2023-03-14

• Fields of study

  Medicine

• Identifiers
  DOI 10.1111/1756-185X.14659PMID 36918366
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Idiopathic inflammatory myopathies

  2021cited by this paper
• Machine learning algorithms reveal unique gene expression profiles in muscle biopsies from patients with different types of myositis

  2020cited by this paper
• The Roles of Tenascins in Cardiovascular, Inflammatory, and Heritable Connective Tissue Diseases

  2020cited by this paper
• Myofiber necroptosis promotes muscle stem cell proliferation via releasing Tenascin-C during regeneration

  2020cited by this paper
• [Idiopathic inflammatory myopathies].

  2019cited by this paper
• 2017 European League Against Rheumatism/American College of Rheumatology classification criteria for adult and juvenile idiopathic inflammatory myopathies and their major subgroups

  2017cited by this paper
• Cardiac involvement in adult and juvenile idiopathic inflammatory myopathies

  2016cited by this paper
• Tenascin-C drives persistence of organ fibrosis

  2016cited by this paper
• Cardiac troponin testing in idiopathic inflammatory myopathies and systemic sclerosis-spectrum disorders: biomarkers to distinguish between primary cardiac involvement and low-grade skeletal muscle disease activity

  2015cited by this paper
• Serum levels of tenascin‐C in collagen diseases

  2013cited by this paper
• An American College of Rheumatology/European League Against Rheumatism Collaborative Initiative

  2013cited by this paper
• Current state of knowledge on aetiology, diagnosis, management, and therapy of myocarditis: a position statement of the European Society of Cardiology Working Group on Myocardial and Pericardial Diseases.

  2013cited by this paper
• 2013 classification criteria for systemic sclerosis: an American college of rheumatology/European league against rheumatism collaborative initiative

  2013cited by this paper
• Raised circulating tenascin-C in rheumatoid arthritis

  2012cited by this paper
• Localized expression of tenascin in systemic sclerosis-associated pulmonary fibrosis and its regulation by insulin-like growth factor binding protein 3.

  2012cited by this paper
• Tenascin-C deficiency attenuates TGF-ß-mediated fibrosis following murine lung injury.

  2010cited by this paper
• Elevated levels of tenascin-C in patients with cryptogenic organizing pneumonia.

  2009cited by this paper

• Polymyositis and dermatomyositis biomarkers.

  2023cites this paper